Ankylose This! Living with Ankylosing Spondylitis

Wednesday, December 27, 2006

Marketing biologics

Don't for a moment forget that when it comes to the biologic (aka TNF-alpha) treatments for ankylosing spondylitis, we are being marketed to: a total of $195 million was spent to market five biologics in the U.S., France and Germany -- direct-to-patient ads in the U.S. ("ask your doctor") only, doctor- and industry-targeted ads throughout. Keep that in mind when reading news coverage about this stuff, because frequently the boundary between PR and news is quite tenuous.

Labels: ,

江西快3预测 看k线图买卖股票 天天海南麻将安装 提供四肖期期准白小姐 一码中大公开你敢买吗 山东体彩11选5开奖结果 重庆麻将规则算账 澳洲幸运8开奖福彩 快乐8官网app 新疆11选5杀号技巧 豪利棋牌